Dr. Shiva Pavan Ponamgi, MD

Dr. Ponamgi practices at CHI Health Immanuel in Omaha, Nebraska, part of CommonSpirit Health.

Dr. Ponamgi's NPI, 1669743118, was assigned on January 14, 2012. Dr. Ponamgi holds Nebraska license 36422.

Dr. Ponamgi's primary practice is CHI Health Immanuel, at 6901 North 72nd St, Omaha, NE 68122 in Douglas County. The practice phone is (402) 572-2121.

Dr. Ponamgi's primary practice is CHI Health Immanuel in Omaha, Nebraska, part of CommonSpirit Health. Dr. Ponamgi is also affiliated with CHI Health Creighton University Medical Center - Bergan Mercy. The medical group on file is CHI Health Clinic. Dmand AI also links Dr. Ponamgi to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ponamgi practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Ponamgi's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Ponamgi's licenses on file in 3 states: Nebraska, Minnesota and New Jersey.

CMS data shows 391 Medicare services from Dr. Ponamgi across 11 procedure codes in 2024, for 296 Medicare patients. Medicare paid $25,142 for them.

CMS counts 296 Medicare patients who saw Dr. Ponamgi in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ponamgi's median patient age at 63, with 52% women.

In 2024, Dr. Ponamgi wrote 485 Medicare Part D claims for 156 patients. 83% of them were for generic drugs. CMS names the drug for 404 of them, across 13 drugs with 11 or more claims each, at $57,839 in total drug cost. In 2023, CMS named 169 claims across 6 drugs.

Dr. Ponamgi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 34 procedures of coronary angioplasty and stenting by Dr. Ponamgi, more than 71% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Ponamgi, published from 2014 to 2022. 2016 was the busiest year, with 6. The most frequent topics are Atrial Fibrillation, Anticoagulants and Stroke. Dr. Ponamgi has published most often in J Interv Card Electrophysiol. Dr. Ponamgi's most frequent co-authors are Samuel J. Asirvatham, MD, Christopher V. Desimone and Vaibhav R. Vaidya, MBBS.

CMS Open Payments shows 110 general payments to Dr. Ponamgi from 17 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 54% of the total. Abbott Laboratories paid the most, $3,832.